In DNA-PKcs-normal and defective glioblastoma cell lines, the treatment triggered the release of cytochrome c to the cytosol, induced apoptotic cell death rather than necrosis, caused DNA damage, decreased telomerase activity and caused disruption of telomeres length maintenance. Here, PRKDC is linked to glioblastoma.